The FDA's approval is based on results from the Phase III DESTINY-Breast09 trial, in which the combo showed a median 40.7-month progression-free survival.

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved additional indications for its PATHWAY anti-HER2/neu (4B5) Rabbit Monoclonal Primary ...

The FDA approved T-DXd plus pertuzumab for HER2-positive metastatic breast cancer, based on DESTINY-Breast09 trial results. The combination therapy reduced disease progression or death risk by 44% ...

Artificial intelligence is reshaping business, but navigating its potential feels like a quest — sometimes bewildering, often unpredictable. This reminds me of one of my favorite movies, “Monty Python ...

The Philadelphia Eagles have tried everything to save their season, but they might have just found someone who can.

Cowboys HC Brian Schottenheimer insists his team’s approach to a Week 15 meeting with Minnesota hasn’t changed.

The Positivity Rabbit didn't go well but veteran A.J. Dillon is dedicated to keeping the vibes high in the Eagles' locker ...

A naked man by the Liberty Bell, the Eagles’ positivity bunny, and the Phillies locking in Schwarber. Here’s this week’s ...

McNabb met Eagles star Cooper DeJean at an autograph signing this week and could not contain his excitement. An absolutely ...

Social media’s effects on children and teens were already a focus for the state’s Child Fatality Task Force. Now, the rapid emergence of artificial intelligence is raising alarms for the legislative ...

The Eagles are the reigning Super Bowl champions and their defense seems to have taken another leap this year. They are in ...

From ownership to players, see how the Eagles are addressing concerns as they aim to avoid another 2023-like collapse in 2025.